Healio

FDA approves Ambelvist MRI contrast agent with lower dose of gadolinium

The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest ...
Nature

Deep learning-based non-contrast MRI model for nasopharyngeal carcinoma diagnosis: an end-to-end gadolinium-free solution

Nasopharyngeal carcinoma (NPC) diagnosis and routine follow-up for recurrence typically rely on contrast-enhanced MRI. This study introduces a deep learning model for diagnosing NPC using only ...
Nature

MU-Diff: a mutual learning diffusion model for synthetic MRI with Application for brain lesions

Synthesizing brain MRI lesions is challenging due to the heterogeneity of lesion characteristics and the complexity of capturing fine-grained pathological information across MRI contrasts.
Hosted on MSN

The Risks and Benefits of MRI Contrast Dye

You are at the healthcare provider’s office, and they tell you that you need an MRI scan with contrast dye. You might feel a little nervous about having chemicals put into your body. You might wonder, ...
GlobalData on MSN

FDA approves Bayer’s Ambelvist contrast agent

The approval is based on global Phase III QUANTI studies evaluating Ambelvist's efficacy and safety in adults and children.
Phys.org

Sharper MRI scans may be on horizon thanks to new physics-based model

Researchers at Rice University and Oak Ridge National Laboratory have unveiled a physics-based model of magnetic resonance relaxation that bridges molecular-scale dynamics with macroscopic magnetic ...
Morningstar

GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation ...

Mangaciclanol, if approved, could transform contrast-enhanced MR imaging by offering an alternative to - or even replacing - gadolinium-based MRI agents A manganese-based MRI contrast agent could ...
Neurology Advisor

FDA Approves Lower-Dose Gadolinium Contrast Agent Ambelvist

The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.